If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> ARCHIVE<br /> Volume 109 Number 1 JANuArY 2014<br /> www.amjgastro.com<br /> official publication of the american college of gastroenterology<br /> leading articles of the month<br /> Clinical and Systematic Reviews<br /> 23 The Role of Thiopurines in Reducing the Need for Surgical<br /> Resection in Crohn’s Disease: A Systematic Review<br /> and Meta-Analysis CME<br /> S. Chatu, V. Subramanian, S. Saxena and R.C.G. Pollok<br /> Esophagus<br /> 52 Objective Manometric Criteria for the Rumination Syndrome<br /> B.F. Kessing, A.J. Bredenoord and A.J.P.M. Smout<br /> Stomach<br /> 60 Effect of Helicobacter pylori Eradication on Metachronous<br /> Recurrence After Endoscopic Resection of Gastric Neoplasm<br /> S.E. Bae, H.-Y. Jung, J. Kang, Y.S. Park, S. Baek, J.-H. Jung, J.Y. Choi,<br /> M.-Y. Kim, J.Y. Ahn, K.-S. Choi, D.H. Kim, J.H. Lee, K.D. Cho<a title="AJG_Vol.109_No.6 page 1" href="http://viewer.zmags.com/publication/60713322?page=1"> ARCHIVE Volume 109 Number 1 JANuArY 2014 www.am</a> <a title="AJG_Vol.109_No.6 page 2" href="http://viewer.zmags.com/publication/60713322?page=2"> VOLUME 109 NUMBER 6 JUNE 2014 www.amjgastro.com </a> <a title="AJG_Vol.109_No.6 page 3" href="http://viewer.zmags.com/publication/60713322?page=3"> NOT ALL PREPS ARE CREATED EQUAL. MoviPrep® vs Su</a> <a title="AJG_Vol.109_No.6 page 4" href="http://viewer.zmags.com/publication/60713322?page=4"> MOVIPREP® (PEG-3350, sodium sulfate, sodium chlor</a> <a title="AJG_Vol.109_No.6 page 5" href="http://viewer.zmags.com/publication/60713322?page=5"> Exciting news for the IBD community INTRODUCING C</a> <a title="AJG_Vol.109_No.6 page 6" href="http://viewer.zmags.com/publication/60713322?page=6"> CCFA Perspectives: IBD Review for Professionals ·</a> <a title="AJG_Vol.109_No.6 page 7" href="http://viewer.zmags.com/publication/60713322?page=7"> www.amjgastro.com The American Journal of</a> <a title="AJG_Vol.109_No.6 page 8" href="http://viewer.zmags.com/publication/60713322?page=8"> Delivering symptomatic relief to IBS sufferers for</a> <a title="AJG_Vol.109_No.6 page 9" href="http://viewer.zmags.com/publication/60713322?page=9"> official publication of the american college</a> <a title="AJG_Vol.109_No.6 page 10" href="http://viewer.zmags.com/publication/60713322?page=10"> †Over a 6-month period; P<0.0001 vs placebo. Ind</a> <a title="AJG_Vol.109_No.6 page 11" href="http://viewer.zmags.com/publication/60713322?page=11"> The following is a brief summary only. See</a> <a title="AJG_Vol.109_No.6 page 12" href="http://viewer.zmags.com/publication/60713322?page=12"> The following is a brief summary only; see full P</a> <a title="AJG_Vol.109_No.6 page 13" href="http://viewer.zmags.com/publication/60713322?page=13"> Lowest volume of active prep solution— only 10 oz</a> <a title="AJG_Vol.109_No.6 page 14" href="http://viewer.zmags.com/publication/60713322?page=14"> (Top) White-light endoscopy shows a reddish color</a> <a title="AJG_Vol.109_No.6 page 15" href="http://viewer.zmags.com/publication/60713322?page=15"> CONTENTS </a> <a title="AJG_Vol.109_No.6 page 16" href="http://viewer.zmags.com/publication/60713322?page=16"> www.amjgastro.com </a> <a title="AJG_Vol.109_No.6 page 17" href="http://viewer.zmags.com/publication/60713322?page=17"> Personality rights of THE WRIGHT BR</a> <a title="AJG_Vol.109_No.6 page 18" href="http://viewer.zmags.com/publication/60713322?page=18"> CHANGE THE WAY YOU TREAT HCV GT 1 PATIENTS A 12-w</a> <a title="AJG_Vol.109_No.6 page 19" href="http://viewer.zmags.com/publication/60713322?page=19"> Dosing information for patients with HCV GT 1 or </a> <a title="AJG_Vol.109_No.6 page 20" href="http://viewer.zmags.com/publication/60713322?page=20"> SOVALDI® (sofosbuvir) Brief summary of full Pre</a> <a title="AJG_Vol.109_No.6 page 21" href="http://viewer.zmags.com/publication/60713322?page=21"> Brief Summary (cont.) Table 2 Percentage of Subj</a> <a title="AJG_Vol.109_No.6 page 22" href="http://viewer.zmags.com/publication/60713322?page=22"> RetroView ™ GivesYouThe Power To See It. One loo</a> <a title="AJG_Vol.109_No.6 page 23" href="http://viewer.zmags.com/publication/60713322?page=23"> PartnerPublishing Superior Science Through Globa</a> <a title="AJG_Vol.109_No.6 page 24" href="http://viewer.zmags.com/publication/60713322?page=24"> </a> <a title="AJG_Vol.109_No.6 page 25" href="http://viewer.zmags.com/publication/60713322?page=25"> </a> <a title="AJG_Vol.109_No.6 page 26" href="http://viewer.zmags.com/publication/60713322?page=26"> BRIEF SUMMARY UCERIS (budesonide) extended releas</a> <a title="AJG_Vol.109_No.6 page 27" href="http://viewer.zmags.com/publication/60713322?page=27"> InActive,MildtoModerateUlcerativeColitis(UC) POWE</a> <a title="AJG_Vol.109_No.6 page 28" href="http://viewer.zmags.com/publication/60713322?page=28"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 29" href="http://viewer.zmags.com/publication/60713322?page=29"> 784 THE RED SECTION What’s Hot in the RED JO</a> <a title="AJG_Vol.109_No.6 page 30" href="http://viewer.zmags.com/publication/60713322?page=30"> THE RED SECTION 785 What’s Hot in the RED JO</a> <a title="AJG_Vol.109_No.6 page 31" href="http://viewer.zmags.com/publication/60713322?page=31"> 786 THE RED SECTION </a> <a title="AJG_Vol.109_No.6 page 32" href="http://viewer.zmags.com/publication/60713322?page=32"> Table 1. Leadership styles • Pacesetting • V</a> <a title="AJG_Vol.109_No.6 page 33" href="http://viewer.zmags.com/publication/60713322?page=33"> 788 THE RED SECTION or resolving a dispute</a> <a title="AJG_Vol.109_No.6 page 34" href="http://viewer.zmags.com/publication/60713322?page=34"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 35" href="http://viewer.zmags.com/publication/60713322?page=35"> 790 THE RED SECTION be taken before a meal</a> <a title="AJG_Vol.109_No.6 page 36" href="http://viewer.zmags.com/publication/60713322?page=36"> THE RED SECTION 791 Table 1. Demographic dat</a> <a title="AJG_Vol.109_No.6 page 37" href="http://viewer.zmags.com/publication/60713322?page=37"> 792 THE RED SECTION </a> <a title="AJG_Vol.109_No.6 page 38" href="http://viewer.zmags.com/publication/60713322?page=38"> may underestimate their symptom severity in an ef</a> <a title="AJG_Vol.109_No.6 page 39" href="http://viewer.zmags.com/publication/60713322?page=39"> 794 THE RED SECTION Appendix A. GSAS </a> <a title="AJG_Vol.109_No.6 page 40" href="http://viewer.zmags.com/publication/60713322?page=40"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 41" href="http://viewer.zmags.com/publication/60713322?page=41"> 796 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.109_No.6 page 42" href="http://viewer.zmags.com/publication/60713322?page=42"> histological scores, which have a certain amount </a> <a title="AJG_Vol.109_No.6 page 43" href="http://viewer.zmags.com/publication/60713322?page=43"> 798 Salkic et al. REVIEW websites of the co</a> <a title="AJG_Vol.109_No.6 page 44" href="http://viewer.zmags.com/publication/60713322?page=44"> Fibro Test for Liver Fibrosis in Chronic Hepatiti</a> <a title="AJG_Vol.109_No.6 page 45" href="http://viewer.zmags.com/publication/60713322?page=45"> 800 Salkic et al. REVIEW 1,245 Records </a> <a title="AJG_Vol.109_No.6 page 46" href="http://viewer.zmags.com/publication/60713322?page=46"> Risk of bias Reference standard Patient sele</a> <a title="AJG_Vol.109_No.6 page 47" href="http://viewer.zmags.com/publication/60713322?page=47"> 802 Salkic et al. REVIEW Study </a> <a title="AJG_Vol.109_No.6 page 48" href="http://viewer.zmags.com/publication/60713322?page=48"> Fibro Test for Liver Fibrosis in Chronic Hepatiti</a> <a title="AJG_Vol.109_No.6 page 49" href="http://viewer.zmags.com/publication/60713322?page=49"> 804 Salkic et al. 1 0.9 0.8 REVIE</a> <a title="AJG_Vol.109_No.6 page 50" href="http://viewer.zmags.com/publication/60713322?page=50"> Study TP FP FN </a> <a title="AJG_Vol.109_No.6 page 51" href="http://viewer.zmags.com/publication/60713322?page=51"> 806 Salkic et al. REVIEW Table 3. Summary o</a> <a title="AJG_Vol.109_No.6 page 52" href="http://viewer.zmags.com/publication/60713322?page=52"> 1 0.9 0.8 0.7 0.6 Sensitivity 0.5 0.</a> <a title="AJG_Vol.109_No.6 page 53" href="http://viewer.zmags.com/publication/60713322?page=53"> 808 Salkic et al. REVIEW this result should</a> <a title="AJG_Vol.109_No.6 page 54" href="http://viewer.zmags.com/publication/60713322?page=54"> 27. Whiting PF, Rutjes AW, Westwood ME; et al. QU</a> <a title="AJG_Vol.109_No.6 page 55" href="http://viewer.zmags.com/publication/60713322?page=55"> 810 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.109_No.6 page 56" href="http://viewer.zmags.com/publication/60713322?page=56"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 57" href="http://viewer.zmags.com/publication/60713322?page=57"> 812 Anglin et al. REVIEW generations of ant</a> <a title="AJG_Vol.109_No.6 page 58" href="http://viewer.zmags.com/publication/60713322?page=58"> disease, age, or sex. A low risk of bias was assi</a> <a title="AJG_Vol.109_No.6 page 59" href="http://viewer.zmags.com/publication/60713322?page=59"> 814 Anglin et al. REVIEW No. of records ide</a> <a title="AJG_Vol.109_No.6 page 60" href="http://viewer.zmags.com/publication/60713322?page=60"> Upper GI Bleeding With SSRI + / - NSAIDs 815 </a> <a title="AJG_Vol.109_No.6 page 61" href="http://viewer.zmags.com/publication/60713322?page=61"> 816 Anglin et al. </a> <a title="AJG_Vol.109_No.6 page 62" href="http://viewer.zmags.com/publication/60713322?page=62"> 7 6 Overall risk ror UGIB 5 4 3 2 1 </a> <a title="AJG_Vol.109_No.6 page 63" href="http://viewer.zmags.com/publication/60713322?page=63"> 818 Anglin et al. REVIEW CLINICAL IMPLICATI</a> <a title="AJG_Vol.109_No.6 page 64" href="http://viewer.zmags.com/publication/60713322?page=64"> 26. Huang ES KH, Strate LL, Chan AT. Selective se</a> <a title="AJG_Vol.109_No.6 page 65" href="http://viewer.zmags.com/publication/60713322?page=65"> 820 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.109_No.6 page 66" href="http://viewer.zmags.com/publication/60713322?page=66"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 67" href="http://viewer.zmags.com/publication/60713322?page=67"> 822 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.109_No.6 page 68" href="http://viewer.zmags.com/publication/60713322?page=68"> alone. We aimed to synthesize the available data </a> <a title="AJG_Vol.109_No.6 page 69" href="http://viewer.zmags.com/publication/60713322?page=69"> 824 Prabhu et al. are defined by I2 thres</a> <a title="AJG_Vol.109_No.6 page 70" href="http://viewer.zmags.com/publication/60713322?page=70"> Synergy of Alcohol and Tobacco on Esophageal Canc</a> <a title="AJG_Vol.109_No.6 page 71" href="http://viewer.zmags.com/publication/60713322?page=71"> 826 Prabhu et al. Chongsuvivatwong </a> <a title="AJG_Vol.109_No.6 page 72" href="http://viewer.zmags.com/publication/60713322?page=72"> importance of focusing efforts to control the wor</a> <a title="AJG_Vol.109_No.6 page 73" href="http://viewer.zmags.com/publication/60713322?page=73"> 828 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.109_No.6 page 74" href="http://viewer.zmags.com/publication/60713322?page=74"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 75" href="http://viewer.zmags.com/publication/60713322?page=75"> 830 Cho et al. ESOPHAGUS treatment (5). Thu</a> <a title="AJG_Vol.109_No.6 page 76" href="http://viewer.zmags.com/publication/60713322?page=76"> HRIM versus TBE 831 mmHg kOhm </a> <a title="AJG_Vol.109_No.6 page 77" href="http://viewer.zmags.com/publication/60713322?page=77"> 832 Cho et al. </a> <a title="AJG_Vol.109_No.6 page 78" href="http://viewer.zmags.com/publication/60713322?page=78"> Table 1. Characteristics of untreated and treated</a> <a title="AJG_Vol.109_No.6 page 79" href="http://viewer.zmags.com/publication/60713322?page=79"> 834 Cho et al. ESOPHAGUS to barium retentio</a> <a title="AJG_Vol.109_No.6 page 80" href="http://viewer.zmags.com/publication/60713322?page=80"> analysis and interpretation, critical revision, a</a> <a title="AJG_Vol.109_No.6 page 81" href="http://viewer.zmags.com/publication/60713322?page=81"> 836 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109_No.6 page 82" href="http://viewer.zmags.com/publication/60713322?page=82"> with traditional pH testing alone (4–8). Further,</a> <a title="AJG_Vol.109_No.6 page 83" href="http://viewer.zmags.com/publication/60713322?page=83"> 838 Patel et al. ESOPHAGUS quantitative mea</a> <a title="AJG_Vol.109_No.6 page 84" href="http://viewer.zmags.com/publication/60713322?page=84"> Acid Parameters on pH-Impedance Testing 839 </a> <a title="AJG_Vol.109_No.6 page 85" href="http://viewer.zmags.com/publication/60713322?page=85"> 840 Patel et al. ESOPHAGUS 1.4%, RET as a c</a> <a title="AJG_Vol.109_No.6 page 86" href="http://viewer.zmags.com/publication/60713322?page=86"> Acid Parameters on pH-Impedance Testing 841 </a> <a title="AJG_Vol.109_No.6 page 87" href="http://viewer.zmags.com/publication/60713322?page=87"> 842 Patel et al. ESOPHAGUS outcome data exi</a> <a title="AJG_Vol.109_No.6 page 88" href="http://viewer.zmags.com/publication/60713322?page=88"> CONFLICT OF INTEREST Guarantor of article: C. Pra</a> <a title="AJG_Vol.109_No.6 page 89" href="http://viewer.zmags.com/publication/60713322?page=89"> 844 Patel et al. ESOPHAGUS 33. Zerbib F, Be</a> <a title="AJG_Vol.109_No.6 page 90" href="http://viewer.zmags.com/publication/60713322?page=90"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 91" href="http://viewer.zmags.com/publication/60713322?page=91"> 846 Nagami et al. ESOPHAGUS in cases where </a> <a title="AJG_Vol.109_No.6 page 92" href="http://viewer.zmags.com/publication/60713322?page=92"> Enrollment (n = 205) Exclusion (n = 3) History o</a> <a title="AJG_Vol.109_No.6 page 93" href="http://viewer.zmags.com/publication/60713322?page=93"> 848 Nagami et al. ESOPHAGUS f </a> <a title="AJG_Vol.109_No.6 page 94" href="http://viewer.zmags.com/publication/60713322?page=94"> RESULTS Background of patients enrolled in this s</a> <a title="AJG_Vol.109_No.6 page 95" href="http://viewer.zmags.com/publication/60713322?page=95"> 850 Nagami et al. Non-magnifying endosco</a> <a title="AJG_Vol.109_No.6 page 96" href="http://viewer.zmags.com/publication/60713322?page=96"> Non-Magnifying NBI for Esophageal Squamous Cell C</a> <a title="AJG_Vol.109_No.6 page 97" href="http://viewer.zmags.com/publication/60713322?page=97"> 852 Nagami et al. ESOPHAGUS (2,10–12). The </a> <a title="AJG_Vol.109_No.6 page 98" href="http://viewer.zmags.com/publication/60713322?page=98"> reduced power. Pirracchio et al. (39) reported th</a> <a title="AJG_Vol.109_No.6 page 99" href="http://viewer.zmags.com/publication/60713322?page=99"> 854 Nagami et al. ESOPHAGUS 25. Yokoyama A,</a> <a title="AJG_Vol.109_No.6 page 100" href="http://viewer.zmags.com/publication/60713322?page=100"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 101" href="http://viewer.zmags.com/publication/60713322?page=101"> 856 Leung et al. ENDOSCOPY widely available</a> <a title="AJG_Vol.109_No.6 page 102" href="http://viewer.zmags.com/publication/60713322?page=102"> 190-NBI for colorectal adenoma 857 569 Pati</a> <a title="AJG_Vol.109_No.6 page 103" href="http://viewer.zmags.com/publication/60713322?page=103"> 858 Leung et al. ENDOSCOPY Definition Comple</a> <a title="AJG_Vol.109_No.6 page 104" href="http://viewer.zmags.com/publication/60713322?page=104"> Table 1. Patient's characteristics 190-NBI </a> <a title="AJG_Vol.109_No.6 page 105" href="http://viewer.zmags.com/publication/60713322?page=105"> 860 Leung et al. First colonoscopy 190-NB</a> <a title="AJG_Vol.109_No.6 page 106" href="http://viewer.zmags.com/publication/60713322?page=106"> 190-NBI for colorectal adenoma 861 Table 3.</a> <a title="AJG_Vol.109_No.6 page 107" href="http://viewer.zmags.com/publication/60713322?page=107"> 862 Leung et al. ENDOSCOPY significantly hi</a> <a title="AJG_Vol.109_No.6 page 108" href="http://viewer.zmags.com/publication/60713322?page=108"> rate serves as a good surrogate marker for qualit</a> <a title="AJG_Vol.109_No.6 page 109" href="http://viewer.zmags.com/publication/60713322?page=109"> 864 EDITORIAL </a> <a title="AJG_Vol.109_No.6 page 110" href="http://viewer.zmags.com/publication/60713322?page=110"> First, there were differences in the endoscopic </a> <a title="AJG_Vol.109_No.6 page 111" href="http://viewer.zmags.com/publication/60713322?page=111"> 866 Chan and Wang ENDOSCOPY 12. McCracken M</a> <a title="AJG_Vol.109_No.6 page 112" href="http://viewer.zmags.com/publication/60713322?page=112"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 113" href="http://viewer.zmags.com/publication/60713322?page=113"> 868 Wu et al. LIVER close monitoring is ess</a> <a title="AJG_Vol.109_No.6 page 114" href="http://viewer.zmags.com/publication/60713322?page=114"> 6 months for immune-tolerant patients. T</a> <a title="AJG_Vol.109_No.6 page 115" href="http://viewer.zmags.com/publication/60713322?page=115"> 870 Wu et al. LIVER Patient demogr</a> <a title="AJG_Vol.109_No.6 page 116" href="http://viewer.zmags.com/publication/60713322?page=116"> Adherence to AASLD Guidelines for CHB Management </a> <a title="AJG_Vol.109_No.6 page 117" href="http://viewer.zmags.com/publication/60713322?page=117"> 872 Wu et al. LIVER Table 2a. Multivariable</a> <a title="AJG_Vol.109_No.6 page 118" href="http://viewer.zmags.com/publication/60713322?page=118"> have significant histologic disease and can be at</a> <a title="AJG_Vol.109_No.6 page 119" href="http://viewer.zmags.com/publication/60713322?page=119"> 874 Wu et al. LIVER and were then sent back</a> <a title="AJG_Vol.109_No.6 page 120" href="http://viewer.zmags.com/publication/60713322?page=120"> 12. Kumar M, Sarin SK, Hissar S et al. Virologic </a> <a title="AJG_Vol.109_No.6 page 121" href="http://viewer.zmags.com/publication/60713322?page=121"> 876 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109_No.6 page 122" href="http://viewer.zmags.com/publication/60713322?page=122"> not always easy; however, both share symptoms suc</a> <a title="AJG_Vol.109_No.6 page 123" href="http://viewer.zmags.com/publication/60713322?page=123"> 878 Rey et al. FUNCTIONAL GI DISORDERS Tabl</a> <a title="AJG_Vol.109_No.6 page 124" href="http://viewer.zmags.com/publication/60713322?page=124"> sociodemographic variables, body mass index, tota</a> <a title="AJG_Vol.109_No.6 page 125" href="http://viewer.zmags.com/publication/60713322?page=125"> 880 Rey et al. 100* </a> <a title="AJG_Vol.109_No.6 page 126" href="http://viewer.zmags.com/publication/60713322?page=126"> The Spectrum of Constipation 881 Table 3. S</a> <a title="AJG_Vol.109_No.6 page 127" href="http://viewer.zmags.com/publication/60713322?page=127"> (%) ** ** *P < 0.05 </a> <a title="AJG_Vol.109_No.6 page 128" href="http://viewer.zmags.com/publication/60713322?page=128"> quite similar characteristics) are patients with </a> <a title="AJG_Vol.109_No.6 page 129" href="http://viewer.zmags.com/publication/60713322?page=129"> 884 Rey et al. FUNCTIONAL GI DISORDERS 33. </a> <a title="AJG_Vol.109_No.6 page 130" href="http://viewer.zmags.com/publication/60713322?page=130"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 131" href="http://viewer.zmags.com/publication/60713322?page=131"> 886 Cremonini and Lembo FUNCTIONAL GI DISORD</a> <a title="AJG_Vol.109_No.6 page 132" href="http://viewer.zmags.com/publication/60713322?page=132"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 133" href="http://viewer.zmags.com/publication/60713322?page=133"> 888 Emmanuel et al. FUNCTIONAL GI DISORDERS </a> <a title="AJG_Vol.109_No.6 page 134" href="http://viewer.zmags.com/publication/60713322?page=134"> RESULTS Patient population and characteristics Fr</a> <a title="AJG_Vol.109_No.6 page 135" href="http://viewer.zmags.com/publication/60713322?page=135"> 890 Emmanuel et al. 10 5 FUNCTIONAL </a> <a title="AJG_Vol.109_No.6 page 136" href="http://viewer.zmags.com/publication/60713322?page=136"> Prucalopride Improves Bowel Function and CTT 8</a> <a title="AJG_Vol.109_No.6 page 137" href="http://viewer.zmags.com/publication/60713322?page=137"> 892 Emmanuel et al. a 70 Normal CTT Slow</a> <a title="AJG_Vol.109_No.6 page 138" href="http://viewer.zmags.com/publication/60713322?page=138"> in those with slow-transit constipation (34). Thi</a> <a title="AJG_Vol.109_No.6 page 139" href="http://viewer.zmags.com/publication/60713322?page=139"> 894 Emmanuel et al. FUNCTIONAL GI DISORDERS </a> <a title="AJG_Vol.109_No.6 page 140" href="http://viewer.zmags.com/publication/60713322?page=140"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 141" href="http://viewer.zmags.com/publication/60713322?page=141"> 896 Navaneethan et al. PANCREAS AND BILIARY </a> <a title="AJG_Vol.109_No.6 page 142" href="http://viewer.zmags.com/publication/60713322?page=142"> Lipids and Bile 897 Table 1. Demographic an</a> <a title="AJG_Vol.109_No.6 page 143" href="http://viewer.zmags.com/publication/60713322?page=143"> P =0.27 Pancreatic CA PSC Chola</a> <a title="AJG_Vol.109_No.6 page 144" href="http://viewer.zmags.com/publication/60713322?page=144"> ACS (nM) : ON-PC: bile AUC = 0.857 1</a> <a title="AJG_Vol.109_No.6 page 145" href="http://viewer.zmags.com/publication/60713322?page=145"> 900 Navaneethan et al. PANCREAS AND BILIARY </a> <a title="AJG_Vol.109_No.6 page 146" href="http://viewer.zmags.com/publication/60713322?page=146"> useful approach for distinguishing the cause of i</a> <a title="AJG_Vol.109_No.6 page 147" href="http://viewer.zmags.com/publication/60713322?page=147"> 902 Navaneethan et al. PANCREAS AND BILIARY </a> <a title="AJG_Vol.109_No.6 page 148" href="http://viewer.zmags.com/publication/60713322?page=148"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 149" href="http://viewer.zmags.com/publication/60713322?page=149"> 904 Sotoudehmanesh et al. PANCREAS AND BILIA</a> <a title="AJG_Vol.109_No.6 page 150" href="http://viewer.zmags.com/publication/60713322?page=150"> PEP was graded as mild, moderate, or severe bas</a> <a title="AJG_Vol.109_No.6 page 151" href="http://viewer.zmags.com/publication/60713322?page=151"> 906 Sotoudehmanesh et al. BILIARY TRACT PANC</a> <a title="AJG_Vol.109_No.6 page 152" href="http://viewer.zmags.com/publication/60713322?page=152"> Indomethacin and Nitrates for PEP 907 Table</a> <a title="AJG_Vol.109_No.6 page 153" href="http://viewer.zmags.com/publication/60713322?page=153"> 908 Sotoudehmanesh et al. PANCREAS AND BILIA</a> <a title="AJG_Vol.109_No.6 page 154" href="http://viewer.zmags.com/publication/60713322?page=154"> 20. Matsushita M, Takakuwa H, Shimeno N et al. Ep</a> <a title="AJG_Vol.109_No.6 page 155" href="http://viewer.zmags.com/publication/60713322?page=155"> 910 EDITORIAL </a> <a title="AJG_Vol.109_No.6 page 156" href="http://viewer.zmags.com/publication/60713322?page=156"> Table 1. The four “P's” of post-endoscopic retrog</a> <a title="AJG_Vol.109_No.6 page 157" href="http://viewer.zmags.com/publication/60713322?page=157"> 912 Arain and Freeman PANCREAS AND BILIARY T</a> <a title="AJG_Vol.109_No.6 page 158" href="http://viewer.zmags.com/publication/60713322?page=158"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 159" href="http://viewer.zmags.com/publication/60713322?page=159"> 914 Auricchio et al. PEDIATRICS count remai</a> <a title="AJG_Vol.109_No.6 page 160" href="http://viewer.zmags.com/publication/60713322?page=160"> (Applied Biosystems, Foster City, CA) on a 7800HT</a> <a title="AJG_Vol.109_No.6 page 161" href="http://viewer.zmags.com/publication/60713322?page=161"> 916 Auricchio et al. Wilks’ lambda. The v</a> <a title="AJG_Vol.109_No.6 page 162" href="http://viewer.zmags.com/publication/60713322?page=162"> 1.0 0.8 Cum survival 0.6 0.4 0.2 0.0 1</a> <a title="AJG_Vol.109_No.6 page 163" href="http://viewer.zmags.com/publication/60713322?page=163"> 918 Auricchio et al. PEDIATRICS Table 3. Ge</a> <a title="AJG_Vol.109_No.6 page 164" href="http://viewer.zmags.com/publication/60713322?page=164"> Table 4. Risk factors associated to development o</a> <a title="AJG_Vol.109_No.6 page 165" href="http://viewer.zmags.com/publication/60713322?page=165"> 920 Auricchio et al. PEDIATRICS The persist</a> <a title="AJG_Vol.109_No.6 page 166" href="http://viewer.zmags.com/publication/60713322?page=166"> them had not developed mucosal damage after 9 yea</a> <a title="AJG_Vol.109_No.6 page 167" href="http://viewer.zmags.com/publication/60713322?page=167"> 922 LETTERS TO THE EDITOR </a> <a title="AJG_Vol.109_No.6 page 168" href="http://viewer.zmags.com/publication/60713322?page=168"> C. difficile treatment type has been associ- ated</a> <a title="AJG_Vol.109_No.6 page 169" href="http://viewer.zmags.com/publication/60713322?page=169"> 924 Letters to the Editor a possible trigg</a> <a title="AJG_Vol.109_No.6 page 170" href="http://viewer.zmags.com/publication/60713322?page=170"> Finally, our cohort included two patients wh</a> <a title="AJG_Vol.109_No.6 page 171" href="http://viewer.zmags.com/publication/60713322?page=171"> 926 Letters to the Editor stratification b</a> <a title="AJG_Vol.109_No.6 page 172" href="http://viewer.zmags.com/publication/60713322?page=172"> G.R.-S., and J.M.A. were responsible for patient </a> <a title="AJG_Vol.109_No.6 page 173" href="http://viewer.zmags.com/publication/60713322?page=173"> 928 Letters to the Editor </a> <a title="AJG_Vol.109_No.6 page 174" href="http://viewer.zmags.com/publication/60713322?page=174"> nature publishing group </a> <a title="AJG_Vol.109_No.6 page 175" href="http://viewer.zmags.com/publication/60713322?page=175"> CLASSIFIEDS General Gastroenterologist Dart</a> <a title="AJG_Vol.109_No.6 page 176" href="http://viewer.zmags.com/publication/60713322?page=176"> www.naturejobs.com Please get in touch with yo</a> <a title="AJG_Vol.109_No.6 page 177" href="http://viewer.zmags.com/publication/60713322?page=177"> CRH O'Regan System Non-Surgical Treatment for Hem</a>